Compare AMAR REMEDIES with Karuturi Global - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs KARUTURI GLOBAL - Comparison Results

KARUTURI GLOBAL 
   Change

Karuturi Global (KGL), based in Bangalore, and having operations in Kenya and Ethiopia, is the world's largest producer of cut roses. The company's total capacity currently stands at around 700 m stems per annum. It cultivates 10 hectares of rose far... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES KARUTURI GLOBAL AMAR REMEDIES/
KARUTURI GLOBAL
 
P/E (TTM) x -0.5 0.5 - View Chart
P/BV x 0.1 0.0 841.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAR REMEDIES   KARUTURI GLOBAL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
KARUTURI GLOBAL
Mar-18
AMAR REMEDIES/
KARUTURI GLOBAL
5-Yr Chart
Click to enlarge
High Rs1643 5,125.0%   
Low Rs861 8,600.0%   
Sales per share (Unadj.) Rs261.61.5 17,064.5%  
Earnings per share (Unadj.) Rs17.40.3 5,014.0%  
Cash flow per share (Unadj.) Rs22.30.6 3,939.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.715.1 667.2%  
Shares outstanding (eoy) m26.161,497.53 1.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.51.4 34.9%   
Avg P/E ratio x7.26.1 118.7%  
P/CF ratio (eoy) x5.63.7 151.1%  
Price / Book Value ratio x1.20.1 892.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,2703,145 104.0%   
No. of employees `000NANA 0.0%   
Total wages/salary Rs m16315 1,116.4%   
Avg. sales/employee Rs ThNM229,590.0-  
Avg. wages/employee Rs ThNM1,460.0-  
Avg. net profit/employee Rs ThNM51,948.0-  
INCOME DATA
Net Sales Rs m6,8442,296 298.1%  
Other income Rs m21239 8.8%   
Total revenues Rs m6,8652,535 270.8%   
Gross profit Rs m1,131638 177.3%  
Depreciation Rs m128328 39.1%   
Interest Rs m39849 815.6%   
Profit before tax Rs m626500 125.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5018 -285.7%   
Tax Rs m121-2 -7,658.2%   
Profit after tax Rs m455519 87.6%  
Gross profit margin %16.527.8 59.5%  
Effective tax rate %19.3-0.3 -6,121.7%   
Net profit margin %6.622.6 29.4%  
BALANCE SHEET DATA
Current assets Rs m4,9044,248 115.4%   
Current liabilities Rs m3,5816,460 55.4%   
Net working cap to sales %19.3-96.3 -20.1%  
Current ratio x1.40.7 208.3%  
Inventory Days Days12410 1,258.7%  
Debtors Days Days100370 27.1%  
Net fixed assets Rs m1,68924,166 7.0%   
Share capital Rs m2621,498 17.5%   
"Free" reserves Rs m2,35821,109 11.2%   
Net worth Rs m2,63522,607 11.7%   
Long term debt Rs m507124 409.9%   
Total assets Rs m6,86229,377 23.4%  
Interest coverage x2.611.3 22.9%   
Debt to equity ratio x0.20 3,517.0%  
Sales to assets ratio x1.00.1 1,276.2%   
Return on assets %12.41.9 642.6%  
Return on equity %17.32.3 751.5%  
Return on capital %31.02.5 1,243.4%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2732,448 11.2%   
Fx outflow Rs m21,928 0.1%   
Net fx Rs m271520 52.1%   
CASH FLOW
From Operations Rs m-313925 -33.8%  
From Investments Rs m-489492 -99.2%  
From Financial Activity Rs m769-1,411 -54.5%  
Net Cashflow Rs m-337 -477.9%  

Share Holding

Indian Promoters % 25.5 5.5 463.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.2 4,600.0%  
FIIs % 0.0 15.8 -  
ADR/GDR % 0.0 1.3 -  
Free float % 65.3 77.2 84.6%  
Shareholders   13,061 70,503 18.5%  
Pledged promoter(s) holding % 99.7 22.4 445.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   EMAMI LTD  LINC PEN & PLASTICS  GILLETTE INDIA  P&G HYGIENE  GODREJ CONSUMER  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed(Closing)

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

Related Views on News

KARUTURI GLOBAL 2017-18 Annual Report Analysis (Annual Result Update)

Jan 17, 2019 | Updated on Jan 17, 2019

Here's an analysis of the annual report of KARUTURI GLOBAL for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of KARUTURI GLOBAL. Also includes updates on the valuation of KARUTURI GLOBAL.

KARUTURI GLOBAL 2017-18 Annual Report Analysis (Annual Result Update)

Jan 17, 2019 | Updated on Jan 17, 2019

Here's an analysis of the annual report of KARUTURI GLOBAL for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of KARUTURI GLOBAL. Also includes updates on the valuation of KARUTURI GLOBAL.

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS